Creating new β cells: Cellular transmutation by genomic alchemy

Journal of Clinical Investigation

Volumn 123, Issue 3, 2013, Pages 1007-

  Moss, Larry G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; HISTONE H3; INSULIN; TRANSCRIPTION FACTOR MAFA; TRANSCRIPTION FACTOR PAX4; TRANSCRIPTION FACTOR PDX 1;

CELL DIFFERENTIATION; CELL POPULATION; DNA METHYLATION; EPIGENETICS; EX VIVO STUDY; GENE EXPRESSION; HISTONE METHYLATION; IN VIVO STUDY; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW;

ANIMALS; EPIGENESIS, GENETIC; GLUCAGON-SECRETING CELLS; HUMANS; INSULIN-SECRETING CELLS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84874623784     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI68348     Document Type: Review

References (36)

1. Willet S, Wright C. Pancreatic plasticity and reprogramming: novel directions towards disease therapy. In: Ainscough J, Yamanaka S, Tada T, eds. Nuclear Reprogramming and Stem Cells.New York, New York, USA: Humana Press; 2011;:193-215.
2. Kroon E, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol. 2008;26(4):443-452. (Pubitemid 351501814)
3. Kojima H, et al. NeuroD-βcellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med. 2003;9(5):596-603. (Pubitemid 36597107)
4. Ferber S, et al. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med. 2000;6(5):568-572. (Pubitemid 30305908)
5. Talchai C, Xuan S, Kitamura T, DePinho RA, Accili D. Generation of functional insulin-producing cells in the gut by Foxo1 ablation. Nat Genet. 2012;44(4):406-412.
6. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature. 2008;455(7213):627-632.
7. Thorel F, et al. Conversion of adult pancreatic α-cells to β-cells after extreme β-cell loss. Nature. 2010;464(7292):1149-1154.
8. Collombat P, et al. The Ectopic Expression of Pax4 in the mouse pancreas converts progenitor cells into α and subsequently β cells. Cell. 2009;138(3):449-462.
9. Chung CH, Hao E, Piran R, Keinan E, Levine F. Pancreatic β-cell neogenesis by direct conversion from mature α-cells. Stem Cells. 2010;28(9):1630-1638.
10. Herrera PL. Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development. 2000;127(11):2317-2322. (Pubitemid 30386571)
11. Bhandare R, et al. Genome-wide analysis of histone modifications in human pancreatic islets. Genome Res. 2010;20(4):428-433.
12. Stitzel ML, et al. Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci. Cell Metab. 2010;12(5):443-455.
13. Tennant BR, et al. Identification and analysis of murine pancreatic islet enhancers [published online ahead of print December 14, 2012]. Diabetologia. doi: 10.1007/s00125-012-2797-5.
14. van Arensbergen J, et al. Derepression of Polycomb targets during pancreatic organogenesis allows insulin-producing β-cells to adopt a neural gene activity program. Genome Res. 2010;20(6):722-732.
15. Ku GM, et al. Research resource: RNA-Seq reveals unique features of the pancreatic β-cell transcriptome. Mol Endocrinol. 2012;26(10):1783-1792.
16. Bramswig NC, et al. Epigenomic plasticity enables human pancreatic α to β cell reprogramming. J Clin Invest. 2013;123(3):1275-1284.
17. Dorrell C, Abraham SL, Lanxon-Cookson KM, Canaday PS, Streeter PR, Grompe M. Isolation of major pancreatic cell types and long-term culture-initiating cells using novel human surface markers. Stem Cell Research. 2008;1(3):183-194.
18. Dorrell C, et al. Transcriptomes of the major human pancreatic cell types. Diabetologia. 2011;54(11):2832-2844.
19. ENCODE Project Consortiumet al. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57-74.
20. Bernstein BE, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell. 2006;125(2):315-326.
21. Vastenhouw NL, Schier AF. Bivalent histone modifications in early embryogenesis. Curr Opin Cell Biol. 2012;24(3):374-386.
22. Pan G, et al. Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell. 2007;1(3):299-312. (Pubitemid 47355329)
23. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. A chromatin landmark and transcription initiation at most promoters in human cells. Cell. 2007;130(1):77-88. (Pubitemid 47031323)
24. Shi X, et al. ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature. 2006;442(7098):96-99. (Pubitemid 44064216)
25. Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet. 2012;13(5):343-357.
26. Levine M. Paused RNA polymerase II as a developmental checkpoint. Cell. 2011;145(4):502-511.
27. Katsuta H, et al. Subpopulations of GFP-marked mouse pancreatic β-cells differ in size, granularity, and insulin secretion. Endocrinology. 2012;153(11):5180-5187.
28. Truax AD, Greer SF. ChIP and Re-ChIP assays: investigating interactions between regulatory proteins, histone modifications, and the DNA sequences to which they bind. Methods Mol Biol. 2012;809:175-188.
29. Xie R, et al. Dynamic chromatin remodeling mediated by polycomb proteins orchestrates pancreatic differentiation of human embryonic stem cells.. Cell Stem Cell. 2013;pii:S1934. -5909(12)00706-0.
30. Lu J, et al. α cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development. Gastroenterology. 2010;138(5):1954-1965.1965 .e1958.
31. Agarwal SK, Jothi R. Genome-wide characterization of menin-dependent H3K4me3 reveals a specific role for menin in the regulation of genes implicated in MEN1-like tumors. PLoS One. 2012;7(5):e37952.
32. James LI, et al. Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain [published online ahead of print January 6, 2013]. Nat Chem Biol. doi: 10.1038/nchembio.1157.
33. Fomina-Yadlin D, et al. Small-molecule inducers of insulin expression in pancreatic-cells. Proc Natl Acad Sci U S A. 2010;107(34):15099-15104.
34. Gu W, et al. Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia. J Pharmacol Exp Ther. 2009;331(3):871-881.
35. Gelling RW. Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci U S A. 2003;100(3):1438-1443. (Pubitemid 36184020)
36. Longuet C, et al. Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor [published online ahead of print November 16, 2012]. Diabetes. doi: 10.2337/db11-1605 .